Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LifeTech Pharmaceuticals, operating as Beijing LaiTai Pharmaceutical, is a Chinese biopharmaceutical company that specializes in the research, development, and manufacturing of modernized Traditional Chinese Medicine (TCM). The company is best known for its proprietary 'Monkey Earring' (Houerhuan) product line, derived from the Pithecellobium clipearia plant, which is marketed as a natural antibiotic and anti-inflammatory treatment for respiratory and oral infections. LifeTech has pioneered a 'Five-in-One' innovation model that integrates clinical research with large-scale industrial production and GAP-certified cultivation bases. In addition to its flagship TCM products, the company has expanded its portfolio to include recombinant proteins like Aflatoxin Detoxifizyme (rADTZ) and innovative anti-viral combination therapies. Following its integration into major pharmaceutical networks, LifeTech continues to play a significant role in addressing global health challenges such as antimicrobial resistance through international collaborations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LifeTech Pharmaceuticals.